ID
24909
Description
Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876
Link
https://clinicaltrials.gov/ct2/show/NCT00291876
Keywords
Versions (1)
- 8/22/17 8/22/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 22, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Hepatitis A Vaccine 14 DAYS POST VACCINATION LABORATORY TESTS NCT00291876
GSK Hepatitis A Vaccine 14 DAYS POST VACCINATION LABORATORY TESTS NCT00291876
Similar models
GSK Hepatitis A Vaccine 14 DAYS POST VACCINATION LABORATORY TESTS NCT00291876
C0600091 (UMLS CUI [1,2])